Loading...
Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study
The stock of therapeutic weapons available in metastatic colorectal cancer (mCRC) has been progressively grown over the years, with improving both survival and patients' clinical outcome: notwithstanding advances in the knowledge of mCRC biology, as well as advances in treatment, fluoropyrimidi...
Saved in:
Published in: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Impact Journals LLC
2021
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869580/ https://ncbi.nlm.nih.gov/pubmed/33613849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27872 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|